Treatment of hepatitis C virus with peg-interferon and ribavirin combination therapy significantly affects lipid metabolism

Shinichiro Tada, Hidetsugu Saito, Hirotoshi Ebinuma, Keisuke Ojiro, Yoshiyuki Yamagishi, Naoki Kumagai, Yasutaka Inagaki, Tetsuya Masuda, Jiro Nishida, Masahiko Takahashi, Hiroshi Nagata, Toshifumi Hibi

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Fingerprint Dive into the research topics of 'Treatment of hepatitis C virus with peg-interferon and ribavirin combination therapy significantly affects lipid metabolism'. Together they form a unique fingerprint.

Medicine & Life Sciences